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I. Introduction
Malaria is a leading cause of childhood morbidity and mortality worldwide. It is estimated to account for 732,000 deaths among children age 5 or less, or about 8% of all such deaths; the share in Africa is 16% ðBlack et al. 2010Þ . The childhood burden of malaria also leaves a lasting adverse imprint on lives and economies ðGallup and Sachs 2001; Sachs and Malaney 2002; Bleakley 2010b; Lucas 2010Þ .
There has been a rapid escalation of malaria control efforts in recent years. Funding committed by major global financiers of malaria control has increased more than ninefold from less than US$0. Kenya adopted a new national malaria strategy in 2001. The strategy emphasized the distribution of insecticide-treated bed nets ðITNsÞ, in line with a large body of evidence that ITNs were effective in reducing malaria. In addition, it recommended selective indoor residual house spraying for epidemic control, a switch to a more effective and prompt treatment of malaria, and prophylactic treatment for pregnant women in endemic areas. Akin to the rest of sub-Saharan Africa, funding for malaria control in Kenya jumped in 2002 and showed major growth by 2005. Figure 1 charts the growth in funding for malaria control in Kenya. 1 The Global Fund, the Presidential Malaria . In the malarious regions, ownership had grown to be in excess of 70%, and the proportion of children protected by ITNs was about 60%.
In this article, I investigate the impact of this rapid intensification of malaria control in Kenya. In particular, I use the quasi-experimental variation induced by preexisting geographical variation in malaria in Kenya coupled with a sharp escalation of the campaign to map out the impact of malaria control on infant mortality. I choose to study the impact in Kenya for two main reasons. First, it has geographically distinct regions with widely varying risk of ma-2 See http://www.theglobalfund.org/en/commitmentsdisbursements/, accessed on April 28, 2011. laria. In particular, some regions have very high risk of malaria and would be expected to benefit greatly from enhanced malaria control activities, while other regions have very low risk of malaria and can usefully serve as controls. Second, there are two conveniently timed Demographic and Health Surveys ðDHS 2003 and DHS 2008-9; see CBS, MOH, and ORC Macro 2004; KNBS and ICF Macro 2010 , respectivelyÞ that permit estimation of trends in infant mortality before and after the intensification of malaria control. The latter survey is recent enough to allow detection of early impact.
I define 2004-8 as the postintensification ðhereafter, "post"Þ and 1993-2003 as the preintensification ðhereafter, "pre"Þ periods. I find large and significant reductions in postneonatal mortality ðdeath in the first 1-11 months of lifeÞ in the post period in the malarious regions relative to the nonmalarious ones. Importantly, the pattern of reduction in infant mortality is consistent with a stylized fact about the burden of malaria in infancy: lifethreatening malaria during infancy usually occurs in the later part of the first year of life, with very young infants enjoying significant clinical protection that is apparently maternally derived. I do not find evidence for similar preexisting differential trends in infant mortality before the post period; the estimate is robust to the inclusion of regional time trends. I also find no evidence of differential changes in maternal or infant care that could explain the sharper reduction in mortality in the malarious regions. There was a boost in funding for an HIV/AIDS program in the same period, but the findings are robust to controlling for any contemporaneous impact of the HIV/AIDS program on mortality. The preferred specification suggests that the renewed malaria campaign led to a fall of 33% in postneonatal mortality in malarious regions that had a mean postneonatal mortality rate of about 75 per 1,000 in the precampaign period.
This finding is consistent with those of several other studies based on admissions and outcomes data from hospitals and health centers in various African countries including Kenya. These studies have noted a dramatic reduction in malaria case load and deaths in parallel with the intensified campaign against malaria, while nonmalaria cases and deaths have remained stable or declined only slowly ðOkiro et al. 2007; O'Meara et al. 2008; Otten et al. 2009; Snow and Marsh 2010; Aregawi et al. 2011Þ. This article adds to the existing literature on the efficacy of ITNs. While clinical trials have found that ITNs are effective against malaria, such trials are characterized by high coverage and close monitoring. This article suggests that ITNs have large health benefits in the context of routine program implementation with coverage rates of about 60% in malarious regions ðfor children under 5 who sleep under ITNsÞ. The article also adds to the rapidly growing set of studies assessing the impact of the recent intensification of malaria control. These studies tend to track changes in outcomes on the basis of patient data from select health facilities. Use of nationally representative survey data such as the DHS allows for a more comprehensive and credible mapping of malaria-related mortality trends as compared to data from health center records and vital statistics registries, which usually have poor coverage in developing country settings.
There has been a recent surge in the literature on the long-run benefits of historical malaria eradication campaigns ðBleakley 2010b; Cutler et al. 2010; Lucas 2010Þ . This article extends this literature to the contemporary context: the renewed campaign against malaria since the early 2000s. It also differs from that literature in two important ways. First, it investigates the impact of contemporary malaria control that is centered on bed nets in contrast to earlier malaria control efforts that were centered on DDT spraying. Second, I focus explicitly on the impact on mortality since the relevant parasite species is Plasmodium falciparum, which causes more deadly malaria than Plasmodium vivax, which is common in most of the settings in that literature. Credible and timely assessment of the extent of mortality and morbidity reductions is critical for sustaining the recent momentum in malaria financing and program implementation.
II. Malaria in Kenya
Malaria is a leading cause of morbidity and mortality in Kenya. It accounts for about 30%-50% of all outpatient visits and 20% of hospital admissions. Pregnant women and children are particularly vulnerable; malaria is estimated to account for about 20% of deaths among children under 5.
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There is wide geographical variation in the risk of malaria in Kenya. Noor et al. ð2009Þ map the malaria risk across Kenya on the basis of Plasmodium falciparum parasite rate ðPf PRÞ data assembled through cross-sectional community-based surveys in 2,095 sites across the country from 1975 to 2009. The PfPR is a commonly used measure of malaria risk in the population: it is the proportion of the population that carries asexual blood stage parasites ðSmith et al. 2007Þ. The mapping shows that over 86% of the Kenyan population resides in areas with very low malaria risk ðPf PR < 5%Þ. Only Nyanza and the Western regions, both around Lake Victoria, have substantial risk of malaria. In Nyanza, over 40%, and in the Western region, about 50%, of the population resides in areas with a high risk of malaria ðPf PR > 40%Þ. In con-trast, four other regions have a very low malaria risk. For instance, the Pf PR for the entire population of Nairobi is less than 0.1%. Table 1 shows the estimated distribution of regional populations by malaria risk. On the basis of this distribution, I estimate the regional malaria risk by taking the weighted average of the midpoints of the malaria risk bands-the weights being the population share in each band. 4 Figure 2 maps this regional distribution of malaria risk. 16 million bed nets were distributed through various channels ðKNBS and ICF Macro 2010Þ.
A. Malaria Control in Kenya
Other major program components include vector control through indoor spraying of houses, prophylactic treatment for all pregnant women, and more prompt and effective treatment of malaria. The National Malaria Strategy recommended selective use of indoor residual spraying ðIRSÞ in the early detection phase of epidemics in the highlands and arid areas. The strategy also aimed to deliver intermittent presumptive treatment in the second and third trimesters to all pregnant women residing in endemic areas as part of routine antenatal care. For case management, the target was to deliver malaria treatment to 60% of all fever cases within 24 hours of the onset of fever. In response to growing drug resistance, in 2006 Kenya switched its first-line treatment protocol for treating uncomplicated cases of malaria. Instead of being treated with sulfadoxine-pyremethamine, malaria cases were now to treated with the more effective artemisinin-based combination therapy that works well against drugresistant strains. presumptive treatment to pregnant women. Access to prompt and effective treatment by artemisinin-based combination therapy has grown slowly due to a number of reasons. There have been frequent drug stock outs due to persistent distribution bottlenecks. Further, much of malaria treatment takes place in the informal sector, and many nonrecommended drugs including substandard antimalarial medicines can be purchased easily over the counter ðChuma et al. 2009Þ . The provision of prophylaxis during pregnancy has been hampered by late presentation of pregnant women for antenatal care, drug stock outs, and a shortage of trained health workers.
The performance review also found that IRS had been implemented annually in epidemic-prone areas since 2005 with support from various donors. IRS campaigns were supported by the British Department for International Development in 2005-9, the Global Fund in 2006-9, and the President's Malaria Initiative in 2007-9. The intensity of IRS campaigns appears to have fluctuated, driven in part by an inconsistent flow of financing. For instance, in 2008, 63% of the targeted houses were sprayed, which afforded protection to about 3.1 million people. But in 2009, only 33% of the target was reached due to delays in donor fund disbursement. Other performance issues are related to lack of proper maps of areas for IRS spraying and poor quality control of pumps and insecticides. In Kenya, the areas west of the Rift Valley and arid and semiarid zones are prone to occasional malaria epidemics. In the current analysis, these areas are included in the nonmalarious regions. To the extent that the IRS campaigns were successful, they likely reduced mortality by mitigating epidemics. Since the nonmalarious regions effectively serve as controls in the analysis, this would create a downward bias in the estimate of the impact on malarious regions.
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B. Effect on Mortality in Early versus Late Infancy
When analyzing the impact of improved malaria control on infant mortality, it is useful to analyze separately the impact on early and late infancy because the morbidity and mortality burden of malaria appears to vary substantially between early infancy and the remainder of the first year of life. Snow et al. ð1998Þ conduct a prospective study of hospital admissions of African infants across four sites with widely varying transmission intensity ðincluding three sites in KenyaÞ. They find evidence of significant clinical protection against severe malaria morbidity in the first 3 months of infancy. This protection does not appear to stem from a lower infection rate-neonates appear to get infected at roughly similar rates as older infants ðKitua et al. 1996Þ. Instead protection in the first few weeks of life appears to be derived from Immu- For the sake of completeness, I also present estimates of the differential impact of the campaign on various phases of infancy, that is, 0 months ðneonatal as beforeÞ, 1-2, 3-5, and 6-11 months.
III. Data and Method
The mortality indicators are calculated from the 1998, 2003, and the 2008-9 Kenya Demographic and Health Surveys. These are nationally representative surveys that collect detailed information on numerous population and health characteristics. The primary respondents are women of reproductive age ð15-49Þ. The women's questionnaire covers topics such as socioeconomic characteristics, complete reproductive history, antenatal and delivery care, immunization of infants, infant and child care, and childhood mortality.
Using the birth history and reported age at death in the DHS, I construct indicators of infant mortality ðdeath within the first year of lifeÞ, neonatal mortality ðwithin the first monthÞ, and postneonatal ð1-11 monthsÞ for each live birth in the sample. 7 The postneonatal and infant mortality indicators are defined only for cohorts that were born at least 1 year before the survey date ðthese indicators are undefined for infants who were alive and younger than 1 year at the time of the surveyÞ. Hence, I restrict the sample to births that took place at least 1 year before the survey date. Since the data related to birth history are retrospective, recall bias is a concern, particularly for the more distant births. I further restrict the analysis to recent births, occurring no earlier than 5 years of the date of the interview. I am constrained to using at least 5 years as the cutoff date for the following reason. If I set the cutoff at 4 years, then using the 2008-9 survey, I would be able The final sample has 13,897 births.
8 To mitigate any gender-specific recall bias, I include gender-specific birth order as fixed effects in all regressions.
The identification strategy relies on preexisting variation across Kenya in malaria risk. I estimate the following linear probability model for the mortality among infants born between 1993 and 2008:
where m ijy is a mortality indicator for infant i born in region j in year y, and g j and r y are region and year of birth fixed effects respectively. The "malaria" variable is the regional estimate of malaria risk as shown in table 1. The "post" dummy denotes years starting in 2004. This is the intervention period that witnessed a rapid intensification of malaria control. The covariates X i include gender of the infant, maternal age, maternal education ðin completed yearsÞ, number of household members, and indicators for multiple birth and place of birth ðrural or urbanÞ. Also included are fixed effects for religion and ethnicity of the head of the household, month of birth ðto capture any seasonal variationÞ, birth order, and gender-specific birth order. 9 The coefficient of in-8 Even with a 5-year recall period, there remains a potential for bias due to selective migration of mothers. In the online appendix, I test and find that the estimates are robust to trimming the sample to the subset of mothers who were resident in the region for at least 5 years or more. 9 The online appendix shows that the main findings are robust to the choice of both individual child-level and household-level covariates.
deaths of children age 0-4 as a proportion of the stock of all children age 0-4 alive in the sample at the start of the year. I find a negative and significant coefficient ðthe same holds for mortality in the 1-4-years age groupÞ.
terest is b, which measures the differential change in infant mortality in the post period for a unit rise in malaria risk.
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Since the errors may be correlated with a region, I estimate cluster-robust standard errors ðMoulton 1986, 1990Þ. However, the cluster-robust standard errors are asymptotically valid only if the number of clusters is large. With a small number of clusters, the cluster-robust standard errors can be biased downward. Since there are only eight clusters ðregionsÞ, I also calculate the two-tailed p-values using the wild cluster bootstrap-T method developed by Cameron, Gelbach, and Miller ð2008Þ.
IV. Results
Before presenting the regression results, it is instructive to examine the sample summary statistics in table 3. The table contains the mean and standard deviation of key variables for births in the pre and post periods by the level of malaria risk. Specifically, the table contrasts the nonmalarious regions ðCen-tral, Coastal, Eastern, Nairobi, North Eastern, and Rift ValleyÞ that have low risk with the malarious regions ðNyanza and WesternÞ that have very high risk. The reported p-values are from a test of difference in means between the malarious and the nonmalarious regions. A higher fraction of births in malarious regions occurs in rural areas and to slightly younger but more educated mothers. 11 The biggest difference between the malarious and the nonmalarious regions is in infant mortality, particularly in the pre period. Table 4 previews the major finding of this article. The table displays the mean infant, neonatal, and postnatal mortality in the pre and post periods for the nonmalarious and the malarious regions. Looking first at the pre period, one finds that infant mortality is much higher in the malarious regions. Al-10 It is worth noting that the Nyanza and Western regions both have a similar level of very high malaria risk, while four of the remaining six regions ðCentral, Eastern, Nairobi, and North EasternÞ have close to zero risk. This suggests an alternative and equivalent approach: a textbook difference-indifference that would use a dummy to tag high malaria risk regions instead of a continuous regional malaria rate variable. The zero-risk regions serve as a control allowing us to account for any secular trends in infant mortality in Kenya. The virtue of this approach would be the ease of interpretation of the relevant coefficient-the prepost change in infant mortality in the high-risk regions relative to the low-risk ones. The downside is that the Coastal and the Rift Valley regions that have small pockets of high malaria risk and bigger pockets of moderate malaria risk would have to be excluded from the analysis. For the sake of completeness, I opt for the estimation strategy in eq. ð1Þ. But I have also estimated a standard difference-in-difference model in which I tag Nyanza and the Western regions as malarious and all six other regions as nonmalarious. The results are essentially similar and available in the online appendix. 11 The religious and ethnic composition of the sample is not reported in table 3 for the sake of brevity. However, the regression analysis controls for differences in religious and ethnic composition across regions. most all of that excess mortality occurs among postneonates-the neonatal mortality is similar in both types of regions. Next, looking at the post period, one finds that infant mortality falls sharply in the malarious regions but declines only modestly in the nonmalarious regions. Further, the relative fall in infant mortality in the malarious regions is driven largely by a sharp reduction in postneonatal mortality.
I now turn to estimating the regression models to assess the magnitude and significance of these differential changes in mortality. The regressions sample includes live births from all eight regions. The results from estimating equation ð1Þ are presented in table 5. For the sake of brevity, only select controls are reported.
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The regression results confirm the basic finding reported in table 4. There is a significant fall in postneonatal mortality in the malarious regions relative to the nonmalarious regions in the post period. There is no such change for neonatal mortality; in fact the coefficient on the post Â malaria interaction is positive albeit insignificant. The total change in infant mortality in the malarious versus nonmalarious regions ðtable 5, col. 3Þ is accordingly smaller than the relative fall in postneonatal mortality. The p-values from the wild cluster bootstrap-T method are reported in square brackets for the coefficient of interest. The estimated impact on postneonatal mortality remains significant at 5%.
V. Robustness Checks
The excess postneonatal mortality in the high-risk regions preintervention is consistent with malaria being a major source of infant mortality in the malarious regions, particularly among postneonatal infants who have lost at least some of the early infancy protection they originally enjoyed. Below, I further explore the pattern of the relative fall in mortality over the course of infancy. The sharper reduction in postneonatal mortality in the malarious regions postintervention suggests that intensified malaria control is having a substantial impact. However, a skeptic may plausibly contend that the relative fall in postneonatal mortality in the malarious areas is not due to the intensification of malaria control but instead due to a relative improvement in other determinants such as maternal and infant care or HIV/AIDS prevention and care or perhaps preexisting differential trends; that is, mortality was already falling faster in the malarious regions. I present results from a series of robustness checks that address these possibilities.
A. Effect on Mortality in Early versus Late Infancy
To track the relative change in mortality over the course of infancy, I construct mortality indicators for the following ages: 0 months ðneonatal as beforeÞ, 1-2, 3-5, and 6-11 months. For each of those indicators, I estimate equation ð1Þ. The coefficients on post Â malaria are plotted in figure 4 . It is evident that the relative postintervention fall in mortality in the malarious regions is entirely concentrated in the postneonatal period ð3-5 and 6-11 monthsÞ. This differential pattern in the change in mortality over the course of the first year of life is strongly suggestive that it is improved malaria control that is driving the reduction in mortality in the malarious regions. 
B. Preexisting Trends in Malarious versus Nonmalarious Regions
Could preexisting trends be driving the observed drop in postneonatal mortality in the malarious regions? To address this possibility, I include regionspecific time trends in equation ð1Þ so that the coefficient on post Â malaria is now estimated from the variation around regional time trends. The results are displayed in column 2 of table 6. To facilitate comparison, column 1 reproduces the results from table 5. The estimated impact on postneonatal mortality is robust to inclusion of regional trends. Note though that the estimate for neonatal mortality becomes positive and significant, suggesting that neonatal mortality had been dropping in the malarious regions in the pre period but reversed course in the post period ðrelative to the nonmalarious regionsÞ. I also check for possible mean reversion by including the average level of the dependent variable for early birth cohorts in each region, interacted with the post dummy. The results are displayed in table 6 column 3. The estimated impact on postneonatal mortality remains negative and significant, although its magnitude is muted. However, this last result should be interpreted with some caution. If the high level of risk in the malarious regions was keeping postneonatal mortality artificially high in those regions, the post Â regional average term could be soaking up some of the malaria effect that would mute the point estimate on post Â malaria. Finally, I use a more flexible specification that separately estimates the relative change in infant mortality in the malarious regions during the campaign buildup ð2002-3Þ and the post period ð2004-8Þ. The choice of 2004-8 as postcampaign was motivated by the observation that ITN usage appeared to take off after 2003. However, the National Malaria Strategy was adopted in 2001, and ITN distribution ðalthough only modestly subsidized and only through the retail sectorÞ commenced in 2002. The results are displayed in table 7. There appears to have been no change in postneonatal mortality during the buildup, and the estimated impact during the post period remains essentially unchanged. 
C. Contemporaneous Programs

Trends in Maternal and Infant care
It is possible that the differential trends in mortality in the malarious regions are being driven not by intensified malaria control but by relative improvements in maternal and infant care in those regions. The DHS data contain useful information on maternal and infant care indicators for births in the 5 years preceding the survey. Table 8 shows the estimates of differential changes in various measures of antenatal care-one or more antenatal visits to health facilities, receiving iron supplements and tetanus typhoid injections, and delivery at a health facility. There appears to be no relative change in the likelihood of receiving antenatal care between the two types of regions-three of the four coefficients on post Â malaria are small and statistically insignificant. If any- thing, antenatal care in the malarious regions may have worsened relative to the low-risk regions; the coefficient for delivery at a health facility is negative and marginally significant. 13 Table 9 shows the results of regressions estimating the relative changes in immunization in the malarious versus nonmalarious regions. I investigate the differential changes in the likelihood of receiving each of the several different vaccines that constitute the immunization schedule in the first year. Immunization is a useful indicator of infant care not merely for any protection it confers on the infant in the first year of life but because it proxies for access to and usage of health services. All the coefficients on post Â malaria are in- 13 The reader may notice that the sample size in table 8 varies across the columns and is in some cases markedly less than the sample size in table 5. This is due to missing data for antenatal care indicators. The key findings remain essentially unchanged if the mortality regressions are run only for the subset of women for whom antenatal care data are available. These results are available on request. Note. Ordinary least squares regression coefficients; other covariates include fixed effects for birth order, gender-specific birth order, religion, ethnicity ðtribeÞ, month of birth, year of birth, and region of birth. Robust standard errors clustered on region of birth in parentheses. Sample includes births from 1993 to 2008, with "post" defined as years after 2003. Only includes births that took place within 1-5 years of the survey date. "Malaria" is the regional Plasmodium falciparum parasite rate. a Indicator for one or more antenatal visits to a health facility. b Public or private health facility. c At the time of the survey. d Limited to births for which the dependent variable is recorded.
significant. There is no evidence of any systematic changes in immunization between malarious and nonmalarious regions; in particular the malarious regions are not doing any better in the post period.
HIV/AIDS
While malaria has traditionally been a major cause of infant mortality in Africa, HIV has recently emerged as another big contributor ðNewell et al.
2004Þ. HIV prevalence in Kenya overlaps to some degree with malaria risk; for example, the Nyanza region, which has high malaria risk, also has the highest HIV prevalence. The Global Fund, which has provided much of the financial support for intensified malaria control in the post period, also funded a major concurrent expansion of HIV prevention and treatment. Early retroviral therapy has been shown to reduce mortality among infected infants by about Note. Ordinary least squares regression coefficients; regressions include fixed effects for birth order, gender-specific birth order, religion, ethnicity ðtribeÞ, month of birth, year of birth, and region of birth. Robust standard errors clustered on region of birth in parentheses. Sample includes births from 1993 to 2008, with "post" defined as years after 2003. Only includes births that took place within 1-5 years of the survey date. "Malaria" is the regional Plasmodium falciparum parasite rate. Immunization schedule for Kenya: BCG ðBacille Calmette-GuérinÞ is given at birth; the oral polio vaccine is given at birth, 6 weeks, and 10 weeks, respectively; DPT (diphtheria, pertussis, and tetanus) 1, 2, and 3 are given at 6, 10, and 14 weeks, respectively; and measles is given at 9 months. a At the time of the survey. b Limited to births for which the dependent variable is recorded. 
VI. Discussion
It is useful to interpret the reported estimates in terms of a more conventional mortality metric ði.e., a rate per 1,000 live birthsÞ. To remain conservative, I choose the coefficient of 2.00066 reported in table 6 for the specification that controls for regional time trends. This estimate maps to a fall in postneonatal mortality of about 25 per 1,000 in the malarious Western region.
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The mean postneonatal mortality rate in the malarious regions in the preperiod was 76 per 1,000 ðsee the bottom panel in table 4Þ . Thus, the estimate implies that the malaria control campaign led to a fall of about 33% in the mean postneonatal mortality rate in the Western region. This is likely an underestimate of the true impact of the campaign in the malarious reasons. The reason is that while I use the change in nonmalarious regions to control for any secular trend in infant mortality across Kenya, those "control" regions were also targeted by the campaign. For instance, there had been a large jump in ITN usage in the nonmalarious regions. And, the IRS has been focused on the epidemic-prone parts of those regions. These campaign activities are likely to have reduced malaria-related mortality in the nonmalarious regions as well. Intuitively, using the relative change in mortality in the malarious regions underestimates the true impact of the campaign in those regions because we are netting out the drop in malaria-related mortality in the nonmalarious regions due to the campaign.
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Using a back-of-the-envelope calculation, I map this finding to an estimate of infant lives saved in the highly malarious regions. Nyanza and the Western regions have a population of about 5.4 and 4.3 million respectively. 17 The birth rate in Kenya is about 3.84 per 100. 18 The point estimate of 20.00066 ðafter controlling for regional time trendsÞ maps to relative drops in postneonatal mortality of about 22 and 25 per 1,000, respectively. That implies on average 4,561 and 4,128 infants saved annually in Nyanza and the Western regions, respectively, during 2004-8, or a total of 43,445 infants over the 5-year period.
Measuring the impact purely in terms of deaths averted understates the benefits of malaria control. Malaria is a major cause of morbidity during pregnancy and early life, and there is a growing body of evidence that in utero and early life exposure to adverse health shocks leave a lasting imprint. Almond ð2006Þ finds that in utero exposure to the 1918 influenza epidemic lowered adult income and schooling for the affected cohorts. Almond and Mazumder ð2011Þ show that in utero exposure to maternal fasting during Ramadan leads to learning disabilities and adverse effects on schooling and income. Barreca ð2010Þ finds that cohorts born in the warmer and wetter months in the early part of the twentieth century in the southern part of the United States have less education; he attributes this to the higher burden of malaria in those months. Bleakley ð2010aÞ provides a recent review of this literature including several studies showing that childhood morbidity due to infection by tropical parasites can permanently scar human capital and reduce income.
Some of these studies explore the long-run impact of malaria eradication campaigns. Just as in this article, the recent studies exploit the quasi-experimental nature of the campaigns: identification stems from preexisting variation in the burden of malaria due to climatic and geographical differences combined with the large and sudden changes in the disease burden due to the campaigns that led to plausibly exogenous spatial and time variation in malaria exposure across birth cohorts. Cutler et al. ð2010Þ find gains in household consumption for cohorts of adult men born in regions of high malaria prevalence during India's malaria eradication campaign of 1950s. Lucas ð2010Þ looks at the impact of malaria eradication campaigns in Paraguay and Sri Lanka and concludes that reducing malaria incidence by 10 percentage points increases completed years of schooling by 0.1 years and the probability of being literate by 1 percentage point. Bleakley ð2010bÞ finds that malaria eradication campaigns of the United States ðca. 1920Þ and Brazil, Columbia, and Mexico ðca. 1955Þ led to higher income and literacy rates among cohorts born in areas with high malaria prevalence ðrelative to cohorts born in areas with low prevalenceÞ. He concludes that being infected with malaria through childhood leads to a reduction in adult income of about 50%. Since the estimates are at the cohort level, any selection and general equilibrium effects are already embedded in that estimate.
VII. Evidence from Other Studies
The findings are consistent with an older and related literature on the efficacy of bed nets. This includes several individual and clustered randomized control trials. Lengeler ð2004Þ provides a comprehensive review. The trials find that, in areas of stable malaria, ITNs reduce the incidence of severe malaria by about 45%. Other studies have found a significant impact on child mortality of past malaria control campaigns. Payne et al. ð1976Þ and Bradley ð1991Þ found that the insecticide-spraying campaigns in Kenya, Nigeria, and Tanzania in the 1950s and 1970s reduced mortality among infants and children age 1-4 years by as much as 40%-50%. Alonso et al. ð1991Þ report that malaria chemoprophylaxis and ITNs reduced children-under-5 mortality by 42% in Gambia. The magnitude of these findings is in line with the 33% drop calculated above.
Of direct relevance are the newer studies of the impact of the recent intensification of malaria control. These studies are typically before-after comparisons using admissions and outcomes data from health facilities; some have a difference-in-difference flavor in that nonmalaria cases and deaths are used as controls. Otten et al. ð2009Þ have investigated the impact of the recent and rapid intensification of malaria control in Rwanda and Ethiopia by tracking inpatient malaria cases and mortality among children under 5 in select sites before ð2001-6Þ and after ð2007Þ nationwide implementation of long-lasting insecticide nets and artemisinin-based combination therapy. They find that malaria cases and deaths fall by 73% and 62%, respectively, in Ethiopia and by 55% and 67%, respectively, in Rwanda. In contrast, they find that nonmalaria cases and deaths remain stable or increase. Similarly, Aregawi et al. ð2011Þ find that the rapid scale-up of malaria control in Zanzibar has reduced malaria deaths and inpatient and outpatient cases at health facilities in Zanzibar by 90%, 78%, and 99. Demombynes and Trommlerová ð2012Þ have used DHS data from Kenya to investigate the recent decline in infant mortality. They also find a sharp fall in postneonatal mortality. They use an Oaxaca-Blinder decomposition to conclude that the use of ITNs in malaria endemic areas explains about 39% of the decline in postneonatal mortality. In contrast, I find that the malaria campaign led to a decline of 58% and 65% in postneonatal mortality in the malarious Nyanza and Western regions, respectively.
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However, in another recent study, Tarozzi et al. ð2011Þ report an unusual finding. They detect no health improvements from increased ownership and usage of ITNs in a large-scale cluster randomized controlled trial in rural Orissa ðIndiaÞ. They discuss at length various possible explanations to reconcile their findings with those of several earlier trials that found large reductions in malaria burden after the distribution of ITNs. They conclude that the most plausible explanation is the relatively low coverage of ITNs and no monitoring of usage in their study. Their trial did not achieve more than 50% coverage in any study village, with the typical coverage rate being significantly less than 50%. Hence, the increase in ITN ownership and usage within study villages was insufficient to break the cycle of malaria transmission. In contrast, most clinical trials have high coverage and close monitoring of usage. These findings raise a question about the true efficacy of ITNs in real-world settings where coverage may be low and usage is not monitored.
How does one reconcile the findings of Tarozzi et al. ð2011Þ with the findings in the current study? One possible explanation is the higher ownership and usage of ITNs in Kenya; the ownership in the highly malarious Nyanza region had risen to about 75% by 2008-9, and about 60% of children under 5 years of age were sleeping under ITNs ðKNBS and ICF Macro 2010Þ. Studies have documented the existence of substantial nonlinearity in the relationship between coverage and health benefits from ITNs ðGimnig et al. Hawley et al. 2003Þ . Another reason could be the difference in settings and the species of the parasite-Plasmodium falciparum in sub-Saharan Africa versus Plasmodium vivax in India-although this remains speculative in the absence of further research. It is instructive to examine the findings of a study from at least one other African setting with comparable ITN coverage ðchildren sleeping under bed netsÞ of about 60%. D'alessandro et al. ð1995Þ conducted a cluster randomized trial of ITN efficacy in villages in five areas of Gambia. Trained health workers impregnated bed nets with insecticide in treatment villages. The researchers estimated that about 60% of children slept under ITNs in the treated villages. Treated and control villages had similar postneonatal mortality before the intervention. After the intervention, postneonatal mortality was 43 per 1,000 in the control villages but only 31 per 1,000 in the treated villages-a drop of about 28%. They also found a drop of 25% in all-cause mortality of older children age 1-9 years, a finding in line with the estimate of the current analysis.
VIII. Conclusion
Kenya has witnessed a major campaign against malaria since the adoption of the National Malaria Strategy in 2001. Funding for the malaria program has risen several fold. The strategy emphasized the use of ITNs, and its biggest achievement had been a large increase in ITN coverage since 2003. Data from health facilities point to a major drop in the burden of malaria. However, it is challenging to construct a representative national picture on the basis of such data due to poor formal health system coverage. I use large preexisting differences in the regional risk of malaria coupled with the sharp timing of the renewed campaign to study the impact on infant mortality. I find that before the intervention, infant mortality in the malarious regions was substantially higher than that in the nonmalarious regions. Much of that difference was due to higher postneonatal mortality in the malarious regions, consistent with a key stylized fact from malaria epidemiology: malaria is most deleterious in later infancy with very young infants enjoying maternally conferred protection. Postintervention, I find a significant fall in postneonatal mortality in the malarious regions vis-à-vis the nonmalarious regions. There is no such relative fall in neonatal mortality. Robustness checks show that the sharp reduction in postneonatal mortality in the malarious regions cannot be explained by preexisting trends. Neither can it be explained by differential changes in maternal and infant care across the two types of regions. Further, the findings are robust to any potential impact on infant mortality of the contemporaneous expansion of HIV/AIDS prevention and treatment.
The preferred specification suggests that the renewed malaria campaign led to a fall in postneonatal mortality of 22-25 per 1,000 live births in the malarious regions. This amounts to a drop of 33% in postneonatal mortality, which maps to an estimated 43,445 infant lives saved in those regions during 2004-8. While clinical trials have already demonstrated the efficacy of ITNs, the findings here suggest large health benefits from the use of ITNs during routine program implementation where coverage is lower and usage is not closely monitored. The findings in this article support the case for sustaining the momentum of the current campaign against malaria.
